Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -122,932 | -97,941 | -257,831 | -192,278 | -178,297 |
| Depreciation Amortization | 7,602 | 9,361 | 109,348 | 19,320 | 20,482 |
| Income taxes - deferred | N/A | N/A | -6,335 | 0 | 0 |
| Accounts receivable | 155 | 397 | 2,755 | 1,890 | -103 |
| Other Working Capital | -4,224 | 4,507 | -160,303 | -82,319 | -101,895 |
| Other Operating Activity | 22,191 | 16,537 | 87,524 | 29,760 | 26,562 |
| Operating Cash Flow | $-97,208 | $-67,139 | $-224,842 | $-223,627 | $-233,251 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 35,840 | 174,686 | 79,456 | 271,596 |
| PPE Investments | -102 | -267 | -21,155 | -20,171 | -23,278 |
| Purchase Of Investment | N/A | N/A | N/A | 0 | -119 |
| Other Investing Activity | 0 | 1,951 | 0 | 0 | 0 |
| Investing Cash Flow | $-102 | $37,524 | $153,531 | $59,285 | $248,199 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74,012 | 29,281 | 16,041 | 86,764 | 36,116 |
| Other Financing Activity | -3,263 | -904 | -1,453 | -2,104 | -3,258 |
| Financing Cash Flow | $70,749 | $28,377 | $14,588 | $84,660 | $32,858 |
| Exchange Rate Effect | 4,091 | -2,048 | 1,483 | 1,254 | -263 |
| Beginning Cash Position | 43,418 | 46,704 | 101,944 | 180,372 | 132,829 |
| End Cash Position | 20,948 | 43,418 | 46,704 | 101,944 | 180,372 |
| Net Cash Flow | $-22,470 | $-3,286 | $-55,240 | $-78,428 | $47,543 |
| Free Cash Flow | |||||
| Operating Cash Flow | -97,208 | -67,139 | -224,842 | -223,627 | -233,251 |
| Capital Expenditure | -102 | -267 | -21,155 | -20,171 | -23,278 |
| Free Cash Flow | -97,310 | -67,406 | -245,997 | -243,798 | -256,529 |